Dynole® 34-2, dynamin I and dynamin II inhibitor
Dynole® 34-2, dynamin I and dynamin II inhibitor
Be the first to review this product! Submit a review
|
(15 Publications)
MW 408.6 Da, Purity >99%. Potent, cell-permeable dynamin I and dynamin II inhibitor (IC50 values are 1.3 and 14.2 μM for inhibition of dynamin I and II GTPase, respectively). Targets the GTPase domain at an allosteric site. Potently inhibits receptor-mediated and synaptic vesicle endocytosis (IC50 values are 5 and 41.1 μM, respectively). 15-fold more active than Dynasore (ab120192) against dynamin I.
別名を表示する
B dynamin, CMT2M, CMTDI1, CMTDIB, DI CMTB, DNM, DNM 1, DYN II, DYN1_HUMAN, DYN2_HUMAN, Dynamin, Dynamin II, Dynamin-1, Dynamin-2
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Dynole® 34-2, dynamin I and dynamin II inhibitor (AB120463)
ab66705 staining PAI1 in HeLa cells treated with dynole-34-2™; (ab120463), by ICC/IF. Increase in PAI1 expression correlates with increased concentration of dynole-34-2™, as described in literature.
The cells were incubated at 37°C for 24h in media containing different concentrations of ab120463 (dynole-34-2™) in DMSO, fixed with 100% methanol for 5 minutes at -20°C and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with ab66705 (5 μg/ml) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight 488 goat anti-rabbit polyclonal antibody (ab96899) at 1/250 dilution was used as the secondary antibody. Nuclei were counterstained with DAPI and are shown in blue.
- FuncS
PubMed
Functional Studies - Dynole® 34-2, dynamin I and dynamin II inhibitor (AB120463)
Primary human monocyte-derived macrophages (HMDM) were incubated with 30 μM of ab120463 for indicated time periods to determine if Dynamin inhibition decreases apoE secretion from primary human macrophages. Dynole-34-2 both dose- and time-dependently decreased apoE secretion without affecting HMDM viability (botton line on the graph as appose to the control, top line).
Kockx et al., PLOS One., 9(10) : e111186. Fig 1F.; doi : https : //doi.org/10.1371/journal.pone.0111186.
Image from Kockx et al., PLOS One., 9(10): e111186. Fig 1F.; doi: https://doi.org/10.1371/journal.pone.0111186. Reproduced under the Creative Commons license http://creativecommons.org/licenses/by/4.0/
- Chemical Structure
Lab
Chemical Structure - Dynole® 34-2, dynamin I and dynamin II inhibitor (AB120463)
2D chemical structure image of ab120463, Dynole® 34-2, dynamin I and dynamin II inhibitor
製品の詳細
出荷温度及び保存条件
出荷温度
短期保存温度
長期保存温度
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Dynamins are involved in essential tasks within cells specifically mediating membrane scission. Dynamin 1 along with Dynamin 2 forms helical structures around the neck of budding vesicles contributing to their detachment from the plasma membrane. These proteins work closely with actin and microtubule networks ensuring proper cytoskeleton-dependent trafficking. Dynamins can also interact with a complex of proteins including amphiphysin and endophilin enhancing their function.
Pathways
Dynamins play significant roles in synaptic vesicle recycling and receptor-mediated endocytosis. These pathways are important for neurotransmitter release and nutrient uptake. In these contexts Dynamins interact with proteins like clathrin and sorting nexin. The GTPase activity of Dynamins is fundamental to their action in these pathways facilitating vesicle budding and fusion events.
文献 (15)
Recent publications for all applications. Explore the full list and refine your search
Viruses 16: PubMed39205315
2024
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 12:1381357 PubMed39108837
2024
Applications
Unspecified application
Species
Unspecified reactive species
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 177:116991 PubMed38906021
2024
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 10:1075364 PubMed36605723
2022
Applications
Unspecified application
Species
Unspecified reactive species
Life (Basel, Switzerland) 11: PubMed34575026
2021
Applications
Unspecified application
Species
Unspecified reactive species
Tissue barriers 9:1929786 PubMed34107845
2021
Applications
Unspecified application
Species
Unspecified reactive species
International immunopharmacology 84:106510 PubMed32361568
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 30:2444-2459.e7 PubMed32075774
2020
Applications
Unspecified application
Species
Unspecified reactive species
Science signaling 11: PubMed30065026
2018
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 7:4580 PubMed28676641
2017
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com